Histogen
Home > About Histogen > News - 2010

<< Back
Renowned Dermatologist Dr. Neil Sadick Joins Histogen Scientific Advisory Board

Human Embryonic-Like Extracellular Matrix Significantly Inhibits Tumor Growth and Cancer Cell Proliferation

Human Extracellular Matrix Significantly Improves Device Biocompatibility

Hypoxia Induces Stem Cell Gene Expression, Protein Production and Cell Surface Markers

HSC Trial Shows Continued Significant Hair Growth at One Year Follow-up

Histogen's proprietary tissue-engineering process is utilized for manufacturing all of Histogen's products. Newborn fibroblasts are placed into a bioreactor and conditioned with a liquid media.
  • ReGenicaTM 's components have recently been shown to be critical for new hair follicle formation
  • The field of stem cell research is rapidly expanding
  • Histogen scientists have developed regenerative medical technologies without the use of stem cells or animal serum
  • Histogen has a foundation of proven products
© Histogen Inc., CA 92101